117 related articles for article (PubMed ID: 2946554)
1. Effect of the antiprogestin RU486 on progesterone production by cultured human granulosa cells: inhibition of the ovarian 3B-hydroxysteroid dehydrogenase.
Dimattina M; Albertson B; Seyler DE; Loriaux DL; Falk RJ
Contraception; 1986 Aug; 34(2):199-206. PubMed ID: 2946554
[TBL] [Abstract][Full Text] [Related]
2. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle.
Garzo VG; Liu J; Ulmann A; Baulieu E; Yen SS
J Clin Endocrinol Metab; 1988 Mar; 66(3):508-17. PubMed ID: 2832438
[TBL] [Abstract][Full Text] [Related]
3. The effects of progesterone receptor blockade in the luteal phase of normal fertile women.
Li TC; Dockery P; Thomas P; Rogers AW; Lenton EA; Cooke ID
Fertil Steril; 1988 Nov; 50(5):732-42. PubMed ID: 3181485
[TBL] [Abstract][Full Text] [Related]
4. Effect of the antiprogestin RU486 on human ovarian steroidogenesis.
DiMattina M; Albertson BD; Tyson V; Loriaux DL; Falk RJ
Fertil Steril; 1987 Aug; 48(2):229-33. PubMed ID: 3497059
[TBL] [Abstract][Full Text] [Related]
5. Interaction of 17 beta-estradiol and progesterone production in human granulosa-luteal cells.
Jalkanen J
Eur J Obstet Gynecol Reprod Biol; 1990 Nov; 37(2):143-53. PubMed ID: 2147013
[TBL] [Abstract][Full Text] [Related]
6. RU486, a progestin antagonist, binds to progesterone receptors in a human endometrial cancer cell line and reverses the growth inhibition by progestins.
Terakawa N; Shimizu I; Tanizawa O; Matsumoto K
J Steroid Biochem; 1988 Aug; 31(2):161-6. PubMed ID: 2457133
[TBL] [Abstract][Full Text] [Related]
7. Interruption of endometrial maturation without hormonal changes by an antiprogesterone during the first half of luteal phase of the menstrual cycle: a contraceptive potential.
Greene KE; Kettel LM; Yen SS
Fertil Steril; 1992 Aug; 58(2):338-43. PubMed ID: 1633899
[TBL] [Abstract][Full Text] [Related]
8. Transformation of human progesterone receptor in the presence of the progestin (R5020) and the antiprogestin (RU486).
Miller MM; Hurd C; Moudgil VK
J Steroid Biochem; 1988 Nov; 31(5):777-83. PubMed ID: 3199817
[TBL] [Abstract][Full Text] [Related]
9. Response to intermittent RU486 in women.
Spitz IM; Croxatto HB; Salvatierra AM; Heikinheimo O
Fertil Steril; 1993 May; 59(5):971-5. PubMed ID: 8486197
[TBL] [Abstract][Full Text] [Related]
10. The effect of RU486 administered during the proliferative and secretory phase of the cycle on the bleeding pattern, hormonal parameters and the endometrium.
Swahn ML; Johannisson E; Daniore V; de la Torre B; Bygdeman M
Hum Reprod; 1988 Oct; 3(7):915-21. PubMed ID: 2846630
[TBL] [Abstract][Full Text] [Related]
11. Luteolytic effect of the antiprogestin and antiglucocorticoid agent RU486 in rats.
Arakawa S; Kambegawa A; Okinaga S; Arai K
J Steroid Biochem; 1990 Aug; 36(5):479-83. PubMed ID: 2214764
[TBL] [Abstract][Full Text] [Related]
12. Difference between R5020 and the antiprogestin RU486 in antiproliferative effects on human breast cancer cells.
Gill PG; Vignon F; Bardon S; Derocq D; Rochefort H
Breast Cancer Res Treat; 1987 Oct; 10(1):37-45. PubMed ID: 3689980
[TBL] [Abstract][Full Text] [Related]
13. Antifertility actions of the progesterone antagonist RU 486 include direct inhibition of placental hormone secretion.
Das C; Catt KJ
Lancet; 1987 Sep; 2(8559):599-601. PubMed ID: 2887889
[TBL] [Abstract][Full Text] [Related]
14. Effects of the antiprogesterone steroid RU 486 during midluteal phase in normal women.
Schaison G; George M; Lestrat N; Reinberg A; Baulieu EE
J Clin Endocrinol Metab; 1985 Sep; 61(3):484-9. PubMed ID: 2991322
[TBL] [Abstract][Full Text] [Related]
15. Direct effects of progesterone and antiprogesterone on human sperm hyperactivated motility and acrosome reaction.
Uhler ML; Leung A; Chan SY; Wang C
Fertil Steril; 1992 Dec; 58(6):1191-8. PubMed ID: 1459270
[TBL] [Abstract][Full Text] [Related]
16. Effect of RU486 on ovarian progesterone production at pro-oestrus and during pregnancy: a possible dual regulation of the biosynthesis of progesterone.
Telleria CM; Deis RP
J Reprod Fertil; 1994 Nov; 102(2):379-84. PubMed ID: 7861391
[TBL] [Abstract][Full Text] [Related]
17. The stimulation of prostaglandin production by two antiprogesterone steroids in human endometrial cells.
Kelly RW; Healy DL; Cameron MJ; Cameron IT; Baird DT
J Clin Endocrinol Metab; 1986 Jun; 62(6):1116-23. PubMed ID: 3457797
[TBL] [Abstract][Full Text] [Related]
18. Luteolytic action of RU486: modulation of luteal 3 beta-hydroxysteroid dehydrogenase and 20 alpha-hydroxysteroid dehydrogenase activities in late pregnant rats.
Tellería CM; Stocco CO; Deis RP
J Steroid Biochem Mol Biol; 1995 Jun; 52(6):567-73. PubMed ID: 7779760
[TBL] [Abstract][Full Text] [Related]
19. Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation.
Croxatto HB; Salvatierra AM; Romero C; Spitz IM
J Clin Endocrinol Metab; 1987 Dec; 65(6):1272-7. PubMed ID: 3119656
[TBL] [Abstract][Full Text] [Related]
20. Effects of progesterone and anti-progesterone RU486 on ovarian 3 beta-hydroxysteroid dehydrogenase activity during ovulation in the gonadotrophin-primed immature rat.
Tanaka N; Iwamasa J; Matsuura K; Okamura H
J Reprod Fertil; 1993 Jan; 97(1):167-72. PubMed ID: 8464007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
